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SelectFlower PowerNatural compounds have long been civilization’s companion,
and yet they still evoke an aura of mystery that transcends
their applications. This may have to do with their origins;
take for instance the ever-dependable aspirin, hailing from
the bark of the willow tree and steeped into a bitter brew
since antiquity. Other molecules such as ascorbic acid, qui-
nine, or penicillin have equally compelling provenances and
colorful histories, but these compounds share another trait
that contributes to their popularity: their ability to be chemi-
cally synthesized. The successful synthesis of many invalu-
able compounds through organic chemistry during the last
century has ushered in the expectation that almost every
molecule may be created on short order, without reliance
on its natural source. This ambition has been partially fulfilled,
as aspirin and many others are today widely available at a
small cost.A poppy herbarium specimen (image from iStock.com/Jochen
Schoenfeld).However, some of the most coveted naturally synthesized
molecules are unexpectedly complex or produced through
poorly characterized biosynthetic pathways, which makes
their manufacture on an industrial scale challenging and
cost ineffective. Understanding the cellular machinery driving
their production may unlock not only a fundamental under-
standing of metabolites but also provide clues to their indus-
trial synthesis. An example of this comes from a recent study
of roses or, more precisely, their scent. For all of the focus
on roses’ ornamental attributes, their fragrance, coveted for
centuries and still used in perfumes, turns out to be one of
the primary drivers for their cultivation. The familiar heavy
scent, encapsulated in oils laboriously distilled from petals,
consists of volatile chemicals, such as monoterpene alco-
hols, whose mix determines the fragrances of distinct culti-
vars. This is well illustrated by the great diversity of roses,
many of which turn out to have lost their fragrance—and their
monoterpenes—perhaps as a trade-off to breeding in otherdesirable traits such as petal color and shape. This observa-
tion prompted Sylvie Baudino, Philippe Hugueney, and
Mohammed Bendahmane to examine the biosynthetic path-
ways of monoterpenes in roses, aimed at deducing the mol-
ecules regulating their production (Magnard et al., 2015).
Genetic and biochemical analysis of two close cultivars
differing in their ability to produce monoterpenes reveals
one key difference in their biosynthetic pathways—the pres-
ence of a protein named RhNUDX1, which hasn’t been previ-
ously associated with monoterpene biosynthesis. RhNUDX1,
a cytoplasmic enzyme found in petals, promotes formation of
the monoterpene geraniol by catalyzing the penultimate step
in its production: the conversion of geranyl monophosphate
from geranyl diphosphate, which is subsequently modified
into geraniol by a putative phosphatase. This unexpected
identification of a new biosynthetic player confirms what
we always suspected—that a secret or two remain hidden
in front of our noses even in the oldest of love stories.
Another facet of the potential for natural compound biosyn-
thesis arises from a string of recent advances that may uncou-
ple the production of morphine from the opium poppy.
Morphine is a natural opiate and potent analgesics for severe
pain and a precursor for other therapeutically important com-
pounds. The medical use of morphine and its derivatives
provides an impetus for decoding its biosynthetic pathways,
eventually allowing their engineering to create a simpler and
more dependable source. Indeed, several recent papers
(DeLoache et al., 2015; Fossati et al., 2015; Thodey et al.,
2014; Winzer et al., 2015) chart the enzymes contributing to
different parts of the pathway and demonstrate the feasibility
of their incorporation into yeast. The dark side of this feat is
the risk that creating such yeast factories may lead the way
to relatively simple opiate production for the illegal drug trade.
Spurred by these concerns and prompted by some of the au-
thors of the studies, policy experts released recommendations
citingmeasures that may be used to contain illegal opiate pro-
duction (Oyeet al., 2015). It is unclearwhenor if suchmeasures
may be needed, but their consideration is a testament to the
rapidly developing field of biosynthetic engineering and the
wide range of applications that it may bring, perhaps fulfilling
the dream of a world in which every compound comes true.REFERENCES
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